StockWatch
·

PHARMAIDS PHARMACEUTICALS LTD. Q3 FY25 Results

PHARMAIDQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue4.7110.1%
Total Income4.7210.2%
Expenditure8.720.3%
PBT-4.0112.6%
Net Profit-3.0217.6%
OPM
NPM-63.92%15.13pp
EPS-0.5524.7%
View full financials

Informational and educational content only. Not investment advice.